| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/29/2008 | US7323465 Alkansulfonamides as endothelin antagonists |
| 01/29/2008 | US7323459 Dissolving olanzapine in a solution of acetic acid and water; filtering the solution; stirring the solution; precipitating the crystalline form by adding a base; and isolating the crystals |
| 01/29/2008 | US7323457 Containing a perhydro-4-benzodiazepinylphenyl group 1-substituted with a methylaminoacetyl-, 4-piperidinylcarbonyl- or 2-pyrrolidinylcarbonyl- group: 4-(Piperidin-4-yl)carbonyl-1-{[2-(2-benzofuranoyl)amino]-4-[1-aminocarbonyl-2-(2-naphthyl)ethylamino]carbonylaminophenyl}homopiperazine; osteoporosis |
| 01/29/2008 | US7323456 Carboxylic acid derivatives compounds and agents comprising the compounds as active ingredient |
| 01/29/2008 | US7323174 Modulation of immune response and methods based thereon |
| 01/29/2008 | CA2417455C Novel cyclooxygenase variants and methods of use |
| 01/29/2008 | CA2406367C Method for treating pain by peripheral administration of a neurotoxin |
| 01/29/2008 | CA2385415C Compositions for regulating desire for smoking |
| 01/29/2008 | CA2342634C Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative |
| 01/29/2008 | CA2323458C Metal chelators for use in the treatment of alzheimer's disease |
| 01/29/2008 | CA2315696C Pharmaceutical composition for oral administration |
| 01/29/2008 | CA2312885C 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof |
| 01/29/2008 | CA2297417C Derivatives of acyl-piperazinyl-pyrimidines, their preparation and application as medicaments |
| 01/29/2008 | CA2226058C 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives |
| 01/29/2008 | CA2093808C Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| 01/24/2008 | WO2008011538A2 Methods of using flavonoids to enhance memory |
| 01/24/2008 | WO2008011503A2 Use of a phage displaying a peptide from an adhesion protein for treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates |
| 01/24/2008 | WO2008011190A1 Cgrp receptor antagonists |
| 01/24/2008 | WO2008011177A2 Medicinal delivery system and related methods |
| 01/24/2008 | WO2008011161A2 Dermal anesthetic compounds |
| 01/24/2008 | WO2008011150A1 Methods of improving the pharmacokinetics of doxepin |
| 01/24/2008 | WO2008010768A1 Method of treating and diagnosing restless legs syndrome and periodic limb movements during sleep and means for carrying out the method |
| 01/24/2008 | WO2008010567A1 Salt or solvate of 5-methyl-2-(piperazin-1-yl)benzenesulfonic acid |
| 01/24/2008 | WO2008010566A1 Crystalline polymorphism of 5-methyl-2-(piperazin-1-yl)benzenesulfonic acid |
| 01/24/2008 | WO2008010511A1 Screening method |
| 01/24/2008 | WO2008010481A1 Aminoindan derivative or salt thereof |
| 01/24/2008 | WO2008010448A1 Novel crystal of substituted phenylalkanoic acid and production process |
| 01/24/2008 | WO2008010362A1 Powder of vitamin e/proline complex and method of producing the same |
| 01/24/2008 | WO2008010223A2 Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use in treating pain and other cns disorders |
| 01/24/2008 | WO2008010222A2 Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating cns disorders |
| 01/24/2008 | WO2008010073A1 Tartrate salt of (7s)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2r)-2-methylpiperazin-1-yl]-6,7-dihydro-5h-cyclopenta[b]pyridine |
| 01/24/2008 | WO2008009954A1 Medical use of cyclin dependent kinases inhibitors |
| 01/24/2008 | WO2008009935A1 Pharmaceutical compositions and their use |
| 01/24/2008 | WO2008009866A2 Combination of modafinil and an antagonist or inverse agonist of the h3 receptor |
| 01/24/2008 | WO2008009750A2 Macrocyclic compounds useful as bace inhibitors |
| 01/24/2008 | WO2008009741A1 Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same |
| 01/24/2008 | WO2008009734A1 Macrocyclic lactams |
| 01/24/2008 | WO2008009639A2 New indications for direct thrombin inhibitors |
| 01/24/2008 | WO2008009476A2 Concentrated methotrexate solutions |
| 01/24/2008 | WO2008009416A1 Spirocyclic azaindole derivatives |
| 01/24/2008 | WO2008009215A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof |
| 01/24/2008 | WO2008009172A1 Controlled release composition and preparation thereof |
| 01/24/2008 | WO2008009151A1 Tannin-free extract of rhodiola rosea l |
| 01/24/2008 | WO2008009141A1 Methods and therapies for potentiating a therapeutic action of an alpha- 2 adrenergic receptor agonist and inhibiting and/or reversing tolerance to alpha- 2 adrenergic receptor agonists |
| 01/24/2008 | WO2007142905A3 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands |
| 01/24/2008 | WO2007136741A3 N-desmethyl-doxepin and methods of using the same to treat sleep disorders |
| 01/24/2008 | WO2007136668A3 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| 01/24/2008 | WO2007135131A8 Substituted pyrazinone derivatives for use as a medicine |
| 01/24/2008 | WO2007130823A3 Polycyclic heterocyclic compounds and their use as modulators of the metabotropic glutamate 5 receptor |
| 01/24/2008 | WO2007124733A3 Use of substituted glycerin derivatives for producing a pharmaceutical preparation |
| 01/24/2008 | WO2007123953A3 Phosphodiesterase 4 inhibitors |
| 01/24/2008 | WO2007113885A3 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them |
| 01/24/2008 | WO2007095147A3 Adhesive preparation comprising sufentanil and methods of using the same |
| 01/24/2008 | WO2007006732A8 Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist) |
| 01/24/2008 | US20080022422 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/24/2008 | US20080021196 Inhibitors of memapsin 2 and use thereof |
| 01/24/2008 | US20080021109 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/24/2008 | US20080021108 Memory Fixation Accelerator |
| 01/24/2008 | US20080021107 Use of amino acids for treatment of various conditions |
| 01/24/2008 | US20080021096 Methods of using flavonoids to enhance memory |
| 01/24/2008 | US20080021094 Treatments for neurogenetic disorders, impulse control disorders, and wound healing |
| 01/24/2008 | US20080021091 Crystalline duloxetine hydrochloride |
| 01/24/2008 | US20080021090 dissolving duloxetine in a first organic solvent (e.g.ethyl acetate) to form a first solution; adding the first solution to a second organic solvent (e.g.ethanol) comprising HCl to form a second solution;allowing duloxetine hydrochloride to crystallize out from second solution; collecting the product |
| 01/24/2008 | US20080021089 Crystalline duloxetine hydrochloride |
| 01/24/2008 | US20080021087 Carbamoylamino-substituted 2,3-dihydro-benzofurans, indoles and benzothiophenes, e.g., (+)-N-((3R)-3-(4-isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide; cerebrovascular disorders |
| 01/24/2008 | US20080021085 Method of reducing abeta42 and treating diseases |
| 01/24/2008 | US20080021083 4-Methylpyrazole Formulations for Inhibiting Ethanol Intolerance |
| 01/24/2008 | US20080021081 e.g. 4'-2-{[(2S)-2-methylpyrrolidin-1-yl]methyl}cyclopropyl)-1,1'-biphenyl-4-carbonitrile; histamine-3 receptor ligand; neuroleptic agent, neurodegenerative diseases, cognition activator; attention-deficit hyperactivity disorder, schizophrenia, Alzheimer's disease, epilepsy, seizures, allergic rhinitis |
| 01/24/2008 | US20080021077 Bioavailability, nontoxic; 2-(3'-Iodo-4'-aminophenyl)-6-methoxybenzothiazole |
| 01/24/2008 | US20080021076 Treatment of Pain |
| 01/24/2008 | US20080021075 Treatment of Pain |
| 01/24/2008 | US20080021074 Pharmaceutical Compositions and Related Methods of Treatment |
| 01/24/2008 | US20080021070 Pyridine derivatives, preparation and therapeutic application thereof |
| 01/24/2008 | US20080021069 Receptor Function Regulating Agent |
| 01/24/2008 | US20080021067 Methods For The Treatment Of Substance Abuse And Addiction |
| 01/24/2008 | US20080021056 Fused, Tricyclic Sulfonamide Inhibitors of Gamma Secretase |
| 01/24/2008 | US20080021052 Novel glucokinase activators and methods of using same |
| 01/24/2008 | US20080021046 USE OF 8-SUBSTITUTED-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES |
| 01/24/2008 | US20080021043 Piperidines and Related Compounds for Treatment of Alzheimer's Disease |
| 01/24/2008 | US20080021042 Composition For Controlling Neuropathic Pain |
| 01/24/2008 | US20080021041 4-piperazinyl-2-phenyl-1-(benzylaminocarbonyl)piperidine derivatives; treatment of conditions mediated by tachykinins, especially emesis, CNS disorders, various kinds of pain, sleep disorders, gastrointestinal disorders and cognitive disorders |
| 01/24/2008 | US20080021039 2-[2-(4-Methoxypyridin-2-yl)ethyl]-6-[4-(4-methylpiperazin-1-yl-sulfonyl)-phenyl]-3H-imidazo-[4,5-b]pyridine,; acute inflammatory diseases: Septic shock, sepsis, SIRS, hemorrhagic shock, organ transplantation and transplant rejection, head trauma, acute lung injury |
| 01/24/2008 | US20080021034 Compositions and methods for modulating gated ion channels |
| 01/24/2008 | US20080021031 Selenophene compounds |
| 01/24/2008 | US20080021029 Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors |
| 01/24/2008 | US20080021025 Inhibitors of cathepsin s |
| 01/24/2008 | US20080021024 Metalloprotease inhibitors |
| 01/24/2008 | US20080021022 (5-(4-Chlorophenyl)isoxazol-4-yl)(3-(pyridin-3-yl)pyrrolidin-1-yl)methanone; enzyme inhibitor of Hydroxysteroid dehydrogenases; treatment of diabetes, obesity |
| 01/24/2008 | US20080021019 immunodeficiencies, cancers, cardiovascular diseases, endocrine disorders, Parkinson's disease, metabolic diseases, tumorigenesis, Alzheimer's disease, heart disease, diabetes, neurodegeneration, inflammation, kidney disease, atherosclerosis and airway disease; substituted pyrazine compounds |
| 01/24/2008 | US20080021017 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 01/24/2008 | US20080021016 Combined Pharmaceutical Composition for the Inhibition of the Decline of Cognitive Functions |
| 01/24/2008 | US20080021014 CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION |
| 01/24/2008 | US20080021007 Substituted Porphyrins |
| 01/24/2008 | US20080021004 Sapogenin derivatives and their use in the treatment of cognitive dysfunction |
| 01/24/2008 | US20080020996 Esters of capsaicin for treating pain |
| 01/24/2008 | US20080020995 Use of Cyclodextrin Complexes Containing Lipoic Acid |
| 01/24/2008 | US20080020988 Brain cell- or nerve cell-protecting agents comprising medicinal ginseng |
| 01/24/2008 | US20080020977 Use of Fullerenes to Oxidize Reduced Redox Proteins |
| 01/24/2008 | US20080020975 Galanin Receptors and Brain Injury |
| 01/24/2008 | US20080020971 Heptanoic acid derivatives as dipeptidyl peptidase inhibitors |